Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
C2H5OH
CAS Number:
Molecular Weight:
46.07
UNSPSC Code:
15101802
PubChem Substance ID:
NACRES:
NA.21
Beilstein/REAXYS Number:
1718733
MDL number:
Product Name
Ethanol Fixative 80% v/v, suitable for fixing solution (blood films)
Quality Level
form
liquid, solution
greener alternative product characteristics
Safer Solvents and Auxiliaries
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
suitability
suitable for fixing solution (blood films)
format
mixture
greener alternative category
SMILES string
CCO
InChI
1S/C2H6O/c1-2-3/h3H,2H2,1H3
InChI key
LFQSCWFLJHTTHZ-UHFFFAOYSA-N
General description
Ethanol Fixative 80% is a solution of 80% v/v ethanol in water. It is used as a preservative for biological specimens in the fluid.
Application
Used as a fixative for blood films in Sigma Procedure 285 for Fetal Hemoglobin
Features and Benefits
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. Ethanol is environmentally preferable green solvent and thus it aligns with "Safer Solvents and Auxiliaries". Click here for more information.
Still not finding the right product?
Explore all of our products under Ethanol Fixative 80% v/v
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
Storage Class
3 - Flammable liquids
wgk
WGK 1
flash_point_f
67.1 °F - closed cup
flash_point_c
19.5 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ross B Mounsey et al.
Experimental neurology, 273, 36-44 (2015-08-06)
Parkinson's disease (PD) is a common chronic neurodegenerative disorder, usually of idiopathic origin. Symptoms including tremor, bradykinesia, rigidity and postural instability are caused by the progressive loss of dopaminergic neurons in the nigrostriatal region of the brain. Symptomatic therapies are
Cem Kuscu et al.
Nature biotechnology, 32(7), 677-683 (2014-05-20)
RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide
N Di Girolamo et al.
Stem cells (Dayton, Ohio), 33(1), 157-169 (2014-06-27)
Stem cell (SC) division, deployment, and differentiation are processes that contribute to corneal epithelial renewal. Until now studying the destiny of these cells in a living mammal has not been possible. However, the advent of inducible multicolor genetic tagging and

